Consolidated Statements of Cash Flows - Manufacturing Group and Finance Group - USD ($) $ in Millions	12 Months Ended
	Dec. 30, 2023	Dec. 31, 2022	Jan. 01, 2022
Cash flows from operating activities
Income from continuing operations	$ 922	$ 862	$ 747
Non-cash items:
Depreciation and amortization	395	397	390
Deferred income taxes	(192)	(220)	23
Asset impairments	88	2	13
Gain on business disposition	0	0	(17)
Other, net	90	94	88
Changes in assets and liabilities:
Accounts receivable, net	(9)	(26)	(58)
Inventories	(359)	(55)	45
Other assets	267	35	(112)
Accounts payable	2	235	13
Other liabilities	276	270	405
Income taxes, net	4	18	11
Pension, net	(202)	(165)	(82)
Other operating activities, net	2	8	2
Net cash provided by (used in) operating activities of continuing operations	1,267	1,490	1,599
Net cash used in operating activities of discontinued operations	(1)	(2)	(1)
Net cash provided by (used in) operating activities	1,266	1,488	1,598
Cash flows from investing activities
Capital expenditures	(402)	(354)	(375)
Net cash used in acquisitions	(1)	(202)	0
Net proceeds (payments) from corporate-owned life insurance policies	40	23	(2)
Proceeds from sale of property, plant and equipment and an insurance recovery	18	22	3
Net proceeds from business disposition	0	0	38
Finance receivables repaid	26	20	19
Other investing activities, net	2	44	36
Net cash provided by (used in) investing activities	(317)	(447)	(281)
Cash flows from financing activities
Net proceeds from long-term debt	348	0	0
Principal payments on long-term debt and nonrecourse debt	(44)	(234)	(621)
Purchases of Textron common stock	(1,168)	(867)	(921)
Proceeds from exercise of stock options	73	44	116
Dividends paid	(16)	(17)	(18)
Other financing activities, net	(6)	(3)	(1)
Net cash used in financing activities	(813)	(1,091)	(1,446)
Effect of exchange rate changes on cash and equivalents	10	(32)	(8)
Net increase (decrease) in cash and equivalents	146	(82)	(137)
Cash and equivalents at beginning of year	2,035	2,117	2,254
Cash and equivalents at end of year	2,181	2,035	2,117
Decrease in short-term debt	0	(14)	(1)
Manufacturing group
Cash flows from operating activities
Income from continuing operations	884	835	740
Non-cash items:
Depreciation and amortization	395	396	380
Deferred income taxes	(188)	(200)	27
Asset impairments	88	2	13
Gain on business disposition	0	0	(17)
Other, net	110	103	97
Changes in assets and liabilities:
Accounts receivable, net	(9)	(26)	(58)
Inventories	(359)	(55)	45
Other assets	261	34	(111)
Accounts payable	2	235	13
Other liabilities	281	277	404
Income taxes, net	5	18	16
Pension, net	(202)	(165)	(82)
Other operating activities, net	2	7	2
Net cash provided by (used in) operating activities of continuing operations	1,270	1,461	1,469
Net cash used in operating activities of discontinued operations	(1)	(2)	(1)
Net cash provided by (used in) operating activities	1,269	1,459	1,468
Cash flows from investing activities
Capital expenditures	(402)	(354)	(375)
Net cash used in acquisitions	(1)	(202)	0
Net proceeds (payments) from corporate-owned life insurance policies	40	23	(2)
Proceeds from sale of property, plant and equipment and an insurance recovery	18	22	3
Net proceeds from business disposition	0	0	38
Finance receivables repaid	0	0	0
Finance receivables originated	0	0	0
Other investing activities, net	0	0	1
Net cash provided by (used in) investing activities	(345)	(511)	(335)
Cash flows from financing activities
Net proceeds from long-term debt	348	0	0
Principal payments on long-term debt and nonrecourse debt	(7)	(18)	(524)
Purchases of Textron common stock	(1,168)	(867)	(921)
Proceeds from exercise of stock options	73	44	116
Dividends paid	(16)	(17)	(18)
Other financing activities, net	(6)	(3)	(1)
Net cash used in financing activities	(776)	(875)	(1,349)
Effect of exchange rate changes on cash and equivalents	10	(32)	(8)
Net increase (decrease) in cash and equivalents	158	41	(224)
Cash and equivalents at beginning of year	1,963	1,922	2,146
Cash and equivalents at end of year	2,121	1,963	1,922
Decrease in short-term debt	0	(14)	(1)
Finance group
Cash flows from operating activities
Income from continuing operations	38	27	7
Non-cash items:
Depreciation and amortization	0	1	10
Deferred income taxes	(4)	(20)	(4)
Asset impairments	0	0	0
Gain on business disposition	0	0	0
Other, net	(20)	(9)	(9)
Changes in assets and liabilities:
Accounts receivable, net	0	0	0
Inventories	0	0	0
Other assets	6	1	(1)
Accounts payable	0	0	0
Other liabilities	(5)	(7)	1
Income taxes, net	(1)	0	(5)
Pension, net	0	0	0
Other operating activities, net	0	0	0
Net cash provided by (used in) operating activities of continuing operations	14	(7)	(1)
Net cash used in operating activities of discontinued operations	0	0	0
Net cash provided by (used in) operating activities	14	(7)	(1)
Cash flows from investing activities
Capital expenditures	0	0	0
Net cash used in acquisitions	0	0	0
Net proceeds (payments) from corporate-owned life insurance policies	0	0	0
Proceeds from sale of property, plant and equipment and an insurance recovery	0	0	0
Net proceeds from business disposition	0	0	0
Finance receivables repaid	169	147	250
Finance receivables originated	(160)	(92)	(100)
Other investing activities, net	2	45	35
Net cash provided by (used in) investing activities	11	100	185
Cash flows from financing activities
Net proceeds from long-term debt	0	0	0
Principal payments on long-term debt and nonrecourse debt	(37)	(216)	(97)
Purchases of Textron common stock	0	0	0
Proceeds from exercise of stock options	0	0	0
Dividends paid	0	0	0
Other financing activities, net	0	0	0
Net cash used in financing activities	(37)	(216)	(97)
Effect of exchange rate changes on cash and equivalents	0	0	0
Net increase (decrease) in cash and equivalents	(12)	(123)	87
Cash and equivalents at beginning of year	72	195	108
Cash and equivalents at end of year	60	72	195
Decrease in short-term debt	$ 0	$ 0	$ 0